Byhealth (300146) Q1 2026 earnings summary

Executive summary

• Achieved operating revenue of ¥1.87 billion in Q1 2026, up 4.30% year-over-year.

• Net profit attributable to shareholders was ¥401.70 million, down 11.62% year-over-year.

• Main brand revenue grew, with offline and online channels both expanding.

Financial highlights

• Operating revenue: ¥1,868,791,728.67, up 4.30% year-over-year.

• Net profit attributable to shareholders: ¥401,703,840.34, down 11.62% year-over-year.

• Net profit excluding non-recurring items: ¥375,430,614.64, down 8.19% year-over-year.

• Operating cash flow: ¥52,270,564.04, down 85.57% year-over-year.

• Basic and diluted EPS: ¥0.24, down 11.11% year-over-year.

Outlook and guidance

• Focus on proactive business development and multi-channel growth.

• Continued investment in key product categories and digital channels.